RFA
EBS icon

Reilly Financial Advisors’s Emergent Biosolutions EBS Stock Holding History

Reilly Financial Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$4K Hold
100
– – ﹤0.01% 881
2021
Q3 		$5K Hold
100
– – ﹤0.01% 741
2021
Q2 		$6K Hold
100
– – ﹤0.01% 766
2021
Q1 		$9K Hold
100
– – ﹤0.01% 713
2020
Q4 		$9K Buy
+100
New +$9.18K ﹤0.01% 640

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Reilly Financial Advisors's EBS Position: Q4 2021 in Review

Reilly Financial Advisors held its Emergent Biosolutions (EBS) position steady in Q4 2021 at 100 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #881.

Reilly Financial Advisors first reported a position in EBS in Q4 2020 and has held it in 5 quarters since. The position peaked at $9K in Q1 2021. 254 funds tracked by Wall St. Rank hold EBS as of Q4 2021.

  • Reilly Financial Advisors held 100 shares of Emergent Biosolutions worth $4K as of Q4 2021.
  • Reilly Financial Advisors left its Emergent Biosolutions share count unchanged in Q4 2021.
  • Emergent Biosolutions made up ﹤0.01% of Reilly Financial Advisors's portfolio in Q4 2021, its #881 holding.
  • Reilly Financial Advisors first reported a position in Emergent Biosolutions in Q4 2020 and has held it in 5 quarters since.
  • Reilly Financial Advisors's Emergent Biosolutions position peaked at $9K in Q1 2021.
  • 254 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2021.

Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.